SUNAYANA VENUGOPAL: Open Payments
NPI 1770187031 · DAWSONVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 29 payments from 15 companies in 2025. Trend: 2023 $973 · 2024 $778 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $148 |
| Lilly USA, LLC | 3 | $52 |
| Corcept Therapeutics | 2 | $51 |
| Amgen Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| Verity Pharmaceuticals Inc. | 1 | $21 |
Products named: Ozempic, Korlym, OTEZLA, Wegovy, AIRSUPRA, JARDIANCE, MOUNJARO, Auvelity.
Industry payments across GA — which companies pay providers there.
